Information:
Fel:
ID
18593
Beskrivning
A Randomized, Open-Label Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT Study Completion
Nyckelord
Versioner (2)
- 2016-11-02 2016-11-02 -
- 2016-11-11 2016-11-11 -
Uppladdad den
11 november 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Study Completion Study Galafold (migalastat) AT1001-012 NCT01218659
Study Completion Study Galafold (migalastat) AT1001-012 NCT01218659
Similar models
Study Completion Study Galafold (migalastat) AT1001-012 NCT01218659
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
reference date
Item
Reference date
date
C1719096 (UMLS CUI [1])
Visit
Item
Visit Type
text
C0545082 (UMLS CUI [1])
eCRF
Item
electronic case report form
text
C1516308 (UMLS CUI [1])
Comment
Item
Comment
text
C0947611 (UMLS CUI [1])
Last day on study
Item
Last day on study
date
C2826674 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
CL Item
Yes, all visits through Visit 9/Month 18 (1a)
CL Item
Yes, all visits through Visit 14/Month 30 (1b)
CL Item
No (3)
Item
Has all data for this patient been entered in the EDC system?
integer
C2707520 (UMLS CUI [1])
CL Item
Yes (1)